Skip to main content

Advertisement

Log in

Tocilizumab Use in Children with Cytokine Release Syndrome

  • Clinical Case Letter
  • Published:
Indian Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Lee DW, Santomasso BD, Locke FL, Ghobadi A, Turtle CJ, Brudno JN, et al. ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells. Biol Blood Marrow Transplant. 2019;25:625–38.

    Article  CAS  Google Scholar 

  2. National Cancer Institute. Common terminology criteria for adverse events (CTCAE). Version 5.0. Accessed August 29, 2019. Available at: https://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_8.5x11.pdf

  3. Liu D, Zhao J. Cytokine release syndrome: Grading, modeling, and new therapy. J Hematol Oncol. 2018;11:121.

    Article  Google Scholar 

  4. Raj RV, Hamadani M, Szabo A, Pasquini MC, Shah NN, Drobyski WR, et al. Peripheral Blood Grafts for T Cell-Replete Haploidentical Transplantation Increase the Incidence and Severity of Cytokine Release Syndrome. Biol Blood Marrow Transplant. 2018;24:1664–70.

    Article  CAS  Google Scholar 

  5. Abboud R, Keller J, Slade M, et al. Severe Cytokine-Release Syndrome after T cell-replete peripheral blood haploidentical donor transplantation is associated with poor survival and anti-IL-6 therapy is safe and well tolerated. Biol Blood Marrow Transplant. 2016;22:1851–60.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ramya Uppuluri.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Raj, R., Uppuluri, R. & VS, V. Tocilizumab Use in Children with Cytokine Release Syndrome. Indian Pediatr 58, 186–187 (2021). https://doi.org/10.1007/s13312-021-2142-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13312-021-2142-5

Navigation